Morning Briefing
Summaries of health policy coverage from major news organizations
States, Insurers Wrestle Over Decisions To Offer Costly Hepatitis C Drug
The medication, named Sovaldi, has shown great promise in fighting the deadly disease, but it is very expensive: The treatment regimen runs about $84,000 per patient.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
